Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Microbiota 9 - March 2020
  3. Modulating gut microbiota in metabolism disorders and alcoholic hepatitis
  • Our publications
    • News
    • HCP Magazine
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • Diagnosis tools
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Microbiota 9 - March 2020
  3. Modulating gut microbiota in metabolism disorders and alcoholic hepatitis
Gastroenterology

Modulating gut microbiota in metabolism disorders and alcoholic hepatitis

Hepatitis

Literature selection

By Pr Markku Voutilainen
Turku University Faculty of Medicine; Turku University Hospital, Department of Gastroenterology, Turku, Finland

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • HCP Magazine
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • Diagnosis tools
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

Alcoholic hepatitis. Light micrograph of a section through a liver affected by hepatitis (inflammation of the liver) caused by excessive alcohol intake.

About this article

Author

Voutilainen Markku Prof Markku Voutilainen
Created 25 August 2021
Updated 12 August 2024

Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention

Liu Y, Wang Y, Ni Y, et al. Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metabolism. 2020 Jan 7;31(1):77-91.e5. 

The impact of exercise on gut microbiota was examined in prediabetic men. Exercise responders had a decrease in fasting insulin and insulin resistance (HOMA-IR), whereas in non-responders they remained unchanged or even deteriorated. Exercise caused increased abundance of Firmicutes, Bacteroides, and Proteobacteria. Alterations of the gut microbiota correlated with the reduction of HOMA-IR. DNA synthesis, amino acid (AA) metabolism, and short chain fatty acid (SCFA) synthesis enhanced in responders. In non-responders, AA fermentation was shifted to production of colonic gases and detrimental compounds, which associate with increased insulin resistance. Increased serum short chain fatty acids, but decreased branched chain amino (BCAA) and aromatic amino acids were detected only in responders. SCFAs have a beneficial role in energy and glucose metabolism, whereas increased BCAAs associate with insulin resistance.

In conclusion, exercise responders’ gut microbiome had enhanced capacity to produce short chain fatty acids but increased breakdown of BCAAs, whereas the microbiome of non-responders produced metabolically detrimental compounds.

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

Duan Y, Llorente C, Lang S, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019 Nov;575(7783):505-511.

Alcoholic hepatitis (AH) patients have increased fecal Enterococcus faecalis (EF), 80% of AH patients are positive for EF. Germ-free mice on ethanol diet were colonized with cytolysin-positive (CL) EF feces of AH patients. Those infected with CL + feces developed a more severe ethanol-induced liver damage. Mice having overgrowth of intestinal enterococci and on ethanol diet were given bacteriophages lysing CL + EF. They developed less severe liver damage. Thus phage therapy may attenuate ethanol-related liver disease caused by CL + EF and improve prognosis in severe AH

Tags
Gastroenterology Microbiome Flora
    Focus
    Microbiota 9 - March 2020
    • Overview
      • Impact of antibiotics on the gut microbiota, does it matter?
    • Commented articles
      • Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease
      • Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota
    • Congress review
      • UEG Week 2019 - Intestinal microbiota: influencing factors and role in certain pathologies
      • ADPW 2019: The growing importance of gut microbiota on digestive health
    • Press review
      • Implication of vaginal microbiota in bacterial vaginosis and candidiasis
      • Skin microbiota : which role in atopic dermatitis and acne?
      • Modulating gut microbiota in metabolism disorders and alcoholic hepatitis
    Created 25 August 2021
    Updated 12 August 2024

    About this article

    To know more about this topic.

    Main topic

    Hepatitis

    Content type

    Press review

    Author

    Voutilainen Markku Prof Markku Voutilainen
    Skin microbiota : which role in atopic dermatitis and acne?
    Focus

    Microbiota 9 - March 2020

    Overview

    Impact of antibiotics on the gut microbiota, does it matter?

    Commented articles

    Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota

    Congress review

    UEG Week 2019 - Intestinal microbiota: influencing factors and role in certain pathologies ADPW 2019: The growing importance of gut microbiota on digestive health

    Press review

    Implication of vaginal microbiota in bacterial vaginosis and candidiasis Skin microbiota : which role in atopic dermatitis and acne? Modulating gut microbiota in metabolism disorders and alcoholic hepatitis
    Gastroenterology
    28.01.2025

    How to rebuild my gut microbiota after taking antibiotics?

    Read the article

    Resilience of healthy adult gut microbiota following antibiotic exposure

    Commented articles - Adults' section By Pr. Harry Sokol ...

    Find out more
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article
    09.02.2022

    Antimicrobial resistance genes “stowaway” in gut microbiota during international travel

    Read the article
    08.01.2024

    When travel breeds antibiotic resistance

    Read the article
    08.03.2024

    Revolutionizing Infection Control: FMT's Role in Combatting Multidrug-Resistant Organisms in Transplant Patients

    Read the article
    Actu PRO : La transplantation fécale, solution à l’antibiorésistance chez les patients immunodéprimés ?
    14.05.2019

    Is fecal transplant a solution to prevent antibiotic resistance in immunocompromised patients?

    Read the article
    13.02.2024

    Antibiotics disrupt cancer immunotherapy via gut and immune effects

    Read the article
    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "HCP Magazine" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    15.10.2025

    How a 7-strain consortium rebuilds the gut to defeat antibiotics resistant bacteria

    Read the article
    Photo HCPs: AMR page for the 2025 WAAW campaign
    08.10.2025

    Everything you need to know about antibiotics and antimicrobial resistance

    Read the article
    07.10.2025

    Phage therapy: a new way to restore the effectiveness of chemotherapy

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "HCP Magazine" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo